Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2024

BUY
N/A
384,948 New
384,948 $311,000
Q2 2023

Aug 14, 2024

BUY
$0.79 - $1.23 $304,108 - $473,486
384,948 New
384,948 $311,000
Q2 2023

Aug 14, 2023

SELL
$0.79 - $1.23 $340,350 - $529,913
-430,824 Closed
0 $0
Q1 2023

May 15, 2024

BUY
$1.04 - $2.77 $400,345 - $1.07 Million
384,948 New
384,948 $446,000
Q2 2022

Aug 14, 2023

BUY
$3.77 - $7.34 $1.62 Million - $3.16 Million
430,824 New
430,824 $2.14 Million
Q1 2022

May 12, 2023

BUY
$5.12 - $19.26 $2.21 Million - $8.3 Million
430,824 New
430,824 $3.06 Million
Q1 2022

May 09, 2022

SELL
$5.12 - $19.26 $2.24 Million - $8.44 Million
-438,004 Closed
0 $0
Q4 2021

Mar 09, 2022

BUY
$17.39 - $25.74 $7.62 Million - $11.3 Million
438,004 New
438,004 $7.96 Million
Q3 2021

Nov 14, 2022

BUY
$19.5 - $50.03 $21.6 Million - $55.5 Million
1,109,104 New
1,109,104 $21.7 Million
Q3 2021

Nov 05, 2021

SELL
$19.5 - $50.03 $8.92 Million - $22.9 Million
-457,579 Closed
0 $0
Q2 2021

Aug 15, 2022

BUY
$36.4 - $52.99 $16.7 Million - $24.2 Million
457,579 New
457,579 $20.5 Million
Q2 2021

Aug 10, 2021

SELL
$36.4 - $52.99 $8.03 Million - $11.7 Million
-220,509 Closed
0 $0
Q1 2021

May 09, 2022

BUY
$44.33 - $89.26 $9.78 Million - $19.7 Million
220,509 New
220,509 $11.1 Million
Q1 2021

May 07, 2021

SELL
$44.33 - $89.26 $620,620 - $1.25 Million
-14,000 Closed
0 $0
Q4 2020

Mar 02, 2021

BUY
$70.38 - $106.0 $985,319 - $1.48 Million
14,000 New
14,000 $1.25 Million
Q4 2020

Feb 10, 2021

SELL
$70.38 - $106.0 $281,520 - $424,000
-4,000 Closed
0 $0
Q3 2020

Nov 12, 2021

BUY
$56.0 - $76.36 $224,000 - $305,440
4,000 New
4,000 $305,000

Others Institutions Holding BLI

About Berkeley Lights, Inc.


  • Ticker BLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,283,904
  • Market Cap $55.3M
  • Description
  • Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and applic...
More about BLI
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.